Preparing for CMS Accreditation: Why AI Governance Should Be on Your Radar

SmartSigma AI Editor
Jun 2
2 min read

As we move through AI integration and adoption in 2026, CMS surveyors are likely to begin focus on AI governance during accreditation surveys. Here's why your organization needs to prepare now.

The data tells a compelling story: 71% of non-federal acute-care hospitals reported using predictive AI in 2024 yet only 38% report high success with AI for clinical risk stratification. With the HHS AI Strategy released in December 2025 and a roughly 70 percent increase in AI use cases during FY 2025, I expect regulatory scrutiny to intensify.

The Oracle Health breach in January 2025—affecting 80 hospitals and millions of patients in part due to poor technology oversight—showed what happens when governance fails. If organizations struggled with basic cybersecurity oversight, how prepared are they to demonstrate AI governance to surveyors?

The Regulatory Landscape

The Trump Administration released "Winning the AI Race: America's AI Action Plan" in July 2025, emphasizing accountability alongside innovation. Key developments:

CMS's WISeR Model launched January 1, 2026, using AI and machine learning for prior authorization review in six states
CMS's April 2025 final rule on Medicare Advantage and AI
HHS directive integrating AI across CMS, CDC, FDA, and NIH

Surveyor Approach

Based on CMS's February 2024 guidance, AI must comply with existing Conditions of Participation:

§482.13 Patient Rights: Informed decision-making when AI influences care §482.21 QAPI: Validation and ongoing monitoring §482.24 Medical Records: Practitioner verification of AI-generated content §482.28 Medical Staff: Competency in AI tool usage §482.42 Infection Prevention: AI surveillance system validation

Some Action Strategies to Prepare

Conduct comprehensive AI inventory with IT and clinical leaders
Establish oversight, risk-stratify systems, address critical gaps

Documentation I Recommend Preparing

Governance & Oversight: AI inventory with risk stratification Technical Validation: Validation studies and ongoing monitoring data Clinical & Patient Protections: Staff training and patient communication protocols

In my experience, surveyors will assess whether your governance is active or performative, whether risk stratification is appropriate, and whether you can demonstrate effective responses when AI performance degrades.

Pitfalls to Compliance

❌ Implementing AI without QAPI oversight ❌ Relying solely on vendor validation ❌ Skipping post-deployment monitoring ❌ Ignoring algorithmic bias and health equity concerns

The Bottom Line

CMS has made clear that existing CoPs apply to AI systems NOW. Organizations that wait to address AI governance will face findings during surveys. The time to prepare is now—before your accreditation survey.